Iq Capital And Northern Gritstone Lead £3.5M Imperagen Seed Funding Round

08/02/22, 8:59 AM

Money raised

£3.5 million

Industry

biotechnology

Round Type

seed

IQ Capital and Northern Gritstone have a led a £3.5 million seed funding round in Imperagen, a life sciences company building unique technology to accelerate the development of enzyme biocatalysts.

Company Info

Company

Imperagen

Additional Info

Imperagen will use the funding to support the development and validation of its ultra-fast enzyme engineering platform.